Advanced Technologies for Detection of Perturbation-Induced Cellular Signatures (U01)

The summary for the Advanced Technologies for Detection of Perturbation-Induced Cellular Signatures (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Advanced Technologies for Detection of Perturbation-Induced Cellular Signatures (U01): Purpose. This FOA encourages grant applications that propose to develop or substantially adapt technologies and methodologies designed to significantly improve the functionality, quality, scope, and/or throughput of perturbation-induced cellular signature data generation. The technologies generated through this FOA are anticipated to accelerate the rate of data generation and the range of signatures that can be identified and characterized by large scale high-throughput perturbation-induced signature collection efforts like The Library of Integrated Network-Based Cellular Signatures (LINCS). Mechanism of Support. This FOA will utilize the U01 award mechanism. It is intended to complement RFA-RM-10-003, Large Scale Production of Perturbagen-Induced Cellular Signatures (U54),that establishes data production efforts to systematize approaches for identifying mechanism-based associations among the effects of disparate biological perturbations and a knowledge base to study functional relationships among the responding cellular components. Released in parallel with this FOA is RFA-RM-10-005, Computational Tool Development and Integrative Data Analysis for LINCS (U01), which seeks to develop innovative computational tools and approaches for the integrative analysis of multiple types of data generated within LINCS. Funds Available and Anticipated Number of Awards. We expect to fund up to four awards in FY2011. Total funds available for the initiative are $2.8M in each of FY2011 and FY2012, contingent upon receiving scientifically meritorious proposals. For this funding opportunity, budgets up to $500,000 direct costs per year and time periods up to two years may be requested.
Federal Grant Title: Advanced Technologies for Detection of Perturbation-Induced Cellular Signatures (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-10-004
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.310
CFDA Descriptions: Trans-NIH Research Support
Current Application Deadline: Feb 22, 2011
Original Application Deadline: Feb 22, 2011
Posted Date: Aug 06, 2010
Creation Date: Aug 06, 2010
Archive Date: Mar 25, 2011
Total Program Funding: $5,600,000
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award:
Expected Number of Awards: 4
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Using Metabolomics to Investigate Biological Pathways and Networks (R01)
Assay Development for High Throughput Molecular Screening (R21)
Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
NINDS Program Project Grant (P01 Clinical Trial Optional)
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com